Myiasis in cancer patients receiving medical care at a reference center Bogotá, Colombia: 2008 – 2018. Case Series
DOI:
https://doi.org/10.35509/01239015.728Keywords:
Miasis, Cáncer, Enfermedades desatendidas, IvermectinaAbstract
Introduction: Myiasis can be considered a neglected disease; it corresponds to the infestation of dipteran larvae in skin,
wounds, or natural cavities. Literature for oncological patients with this infestation is limited for Colombia.
Methods: A case series of myiasis was carried out in patients treated at the National Cancer Institute of Colombia from 2008
to 2018. Data were obtained from medical records in order to characterize sociodemographic and oncological variables and
the treatment received.
Results: Thirty-two records were found, 27 of them met the inclusion criteria. Median age was 69 years, 74% were men,
48% came from rural areas, 33.3% from areas with altitudes greater than 2,000 meters above sea level, 70% had head
and neck cancer, followed by breast cancer in 14%; 40% had ECOG 2-3, and 77% visualized larvae before consulting. No
patient presented with sepsis at the time of consultation, 29% presented with discharge in the infested area, 85% received
ivermectin and treatment by the nursing staff; 70% received systemic antibiotics, and 60% other treatments in addition to
mechanical removal and ivermectin. Median of leukocytes at admission was 10,280, while median of eosinophils was 110.
Conclusion: This is the first reported case series of myiasis in cancer patients for Latin America. It is more common in
patients with neoplasms in exposed areas, although it can occur in unexposed areas too. Larval infestation tends not to be
purulent. Further studies are needed on the use of ivermectin, other antibiotics, and the prognostic implications of this
pathology in patients with advanced cancer.
Author Biographies
Sonia Cuervo-Maldonado, Grupo Infectología, Instituto Nacional de Cancerología ESE, Bogotá, Colombia
GREICAH: Grupo de Investigación en Enfermedades Infecciosas en Cáncer y Alteraciones Hematológicas. Bogotá, Colombia
Julio Gomez-Rincon, Grupo Infectología, Instituto Nacional de Cancerología ESE. Bogotá, Colombia
GREICAH: Grupo de Investigación en Enfermedades Infecciosas en Cáncer y Alteraciones Hematológicas. Bogotá, Colombia
References
Hall MJ, Wall RL, Stevens JR. Traumatic Myiasis: A Neglected Disease in a Changing World. Annu Rev Entomol. 2016;61:159-76.
Francesconi F, Lupi O. Myiasis. Clin Microbiol Rev. 2012 Jan;25(1):79-105.
Biswas S McNerney P. Myiasis on a giant squamous cell carcinoma of the scalp: a case report review of relevant literature. World J Oncol. 2016;7(2-3):34-39.
Calvopina M, Ortiz-Prado E, Castañeda B, Cueva I, Rodríguez-Hidalgo R, Cooper P. Human myiasis in Ecuador. Plos Negl Trop Dis. 2020;14(2):e0007858. https://doi.org/10.1371/journal.pntd.0007858
Singh A, Singh Z. Incidence of myiasis among humans-a review. Parasitol Res. 2015 Sep;114(9):3183-99.
González C, Salamanca JC, Olano VA, Pérez CF. Miasis cavitaria. Reporte de un caso. Revista Med. 2008;16(1):95-98.
Ruiz-Zapata JD, Figueroa-Gutierrez LM, Mesa-Franco JA, Moreno-Gutiérrez PA. Umbilical Myiasis by Cochliomyia hoominivorax in an infant in Colombia. Front Med. 2020;6:92 https://doi.org/10.3389/fmed.2019.00292.
Villamil-Gómez WE, Cardona-Ospina J, Prado-Ojeda JS, Hernández-Prado H, Figueroa M, Causil-Morales PN, Pérez-Reyes K, Palechor-Ocampo LA, Rodríguez-Morales AJ. Pin-site Myiasis caused by screwworm fly in non-healed wound, Colombia. Emerging infectious Diseases. 2019;25(2):379-380.
Osorio J, Moncada L, Molano A, et al. Role of ivermectin in the treatment of severe orbital myiasis due to Cochliomyia hominivorax. Clin Infect Dis. 2006 Sep 15;43(6):e57-9.
Africano FJ, Faccini-Martínez ÁA, Pérez CE, Espinal A, Bravo JS, Morales C. Pin-site myiasis caused by screwworm fly, Colombia. Emerg Infect Dis. 2015 May;21(5):905-6.
Lazaro SA, Gordillo FD, De Carli JP, Trentin MS, Dogenski LC, De Conto F. Treatment of facial myiasis in an eldery patient with oral squamous cell carcinoma: Case report. Int J Surgery. Case rerpots. 2020;71:260-265.
Almeida JA, De Oliveira LV, Jayme PU, Leal E, Callou G, AlvesR, Calcavanti B. Head and neck myiasis: a case series and review ot the literature. Oral and maxillofacial surgery.2017;124(5):e249-e256. https://doi.org/10.1016/j.0000.2017.06.120.
Patel BC, Ostwal S, Sanghavi PR, Joshi G, Singh R. Management of Malignant Wound Myiasis with Ivermectin, Albendazole, and Clindamycin (Triple Therapy) in Advanced Head-and-Neck Cancer Patients: A Prospective Observational Study. Indian J Palliat Care. 2018 Oct-Dec;24(4):459-464.
Sayced A, Ahmed A, Sharma SC, Hasan SA. Ivermectin a novel of treatment of nasal and nasopharyngeal myiasis. Indian J Otolaryngology and Head and Neck Surgery. )Indian J Otolaryngol Head Neck Surg. 2019;71:2019-2024.
Fernandes LF, Pimenta FC, Fernandes FF. First report of human myiasis in Goiás state, Brazil: frequency of different types of myiasis, their various etiological agents, and associated factors. J Parasitol. 2009 Feb;95(1):32-8.
Sherman RA. Wound myiasis in urban and suburban United States. Arch Intern Med. 2000 Jul 10;160.
Pinilla B., T.; Acuña, Y.; Cortes B., D.; Díaz R., A.; Segura, A.; Bello, F.J.: Ciclo biológico y dietas de Lucilia sericata Rev. U.D.C.A Act. & Div. Cient. 13 (2): 153-161, 2010
Osorio J, Moncada U, Segura A. Arias F. Torres RD, Sussman O. Miasis autóctona de Bogotá. lnfectio.2008;12:101.
Batista-da-Silva JA, Moya-Borja GE, Queiroz MM. Factors of susceptibility of human myiasis caused by the New World screw-worm, Cochliomyia hominivorax in São Gonçalo, Rio de Janeiro, Brazil. J Insect Sci. 2011;11:14.
Rodríguez Diego Jesús Gregorio, Olivares Orozco Javier Lorenzo, Sánchez Castilleja Yolanda, Arece García Javier. El Gusano Barrenador del Ganado, Cochliomyia hominivorax (Diptera: Calliphoridae): un problema en la salud animal y humana. Rev Salud Anim; 38( 2 ): 120-130.
Visciarelli E, Costamagna S, Lucchi L, Basabe N. Human myiasis in Bahía Blanca, Argentina: Period 2000/2005. Neotrop Entomol 2007;36(4):605-11.
Girardeau FM, Scrofernecker ML. Myiasis in patients with head and neck cancer: Seldom described but commonly seen. Ear Nose Throat J. 2017 Jul;96(7):E19-E22.
Gopalakrishnan S, Srinivasan R, Saxena SK, Shanmugapriya J. Myiasis in different types of carcinoma cases in southern India. Indian J Med Microbiol. 2008 Apr-Jun;26(2):189-92
Ahmed SS, Ahmed W, Bey A. Myiasis of Maxilla: Report of a Case. Int J Clin Pediatr Dent. 2011;4(3):248-249. https://doi.org/10.5005/jp-journals-10005-1119
Otranto D. The immunology of myiasis: parasite survival and host defense strategies. Trends Parasitol. 2001 Apr;17(4):176-82.
Ribeiro FAQ, Pereira CSB, Alves AA, Marcon MA. Treatment of human cavitary myiasis with oral ivermectin. Rev Bras Otorrinolaringol. 2001;67(6):755-761.
Robson MC, Payne WG, Ko F, Mentis M, Donati G, Shafii SM, Culverhouse S, Wang L, Khosrovi B, Najafi R, Cooper DM, Bassiri M. Hypochlorous Acid as a Potential Wound Care Agent: Part II. Stabilized Hypochlorous Acid: Its Role in Decreasing Tissue Bacterial Bioburden and Overcoming the Inhibition of Infection on Wound Healing. J Burns Wounds. 2007 Apr 11;6:e6
Gross BG. Cardiac arrhythmias during phenol face peeling. Plast Reconstr Surg. 1984 Apr;73(4):590-4
Vearrier D, Jacobs D, Greenberg MI. Phenol Toxicity Following Cutaneous Exposure to Creolin®: A Case Report. J Med Toxicol. 2015 Jun;11(2):227-31.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Colombiana de Cancerología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Todos los derechos reservados.
